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Abstract
Apoptosis of fibroblasts may be key for the removal of cells following repair processes. Contraction
of three-dimensional collagen gels is a model of wound healing and remodeling. Here two potent
inducers of contraction, TGF-β1 and fetal calf serum (FCS) were evaluated for their effect on
fibroblast apoptosis in contracting collagen gels. Human fetal lung fibroblasts were cultured in
floating type I collagen gels, exposed to TGF-β1 or FCS, and allowed to contract for 5 days.
Apoptosis was evaluated using TUNEL and confirmed by DNA content profiling. Both TGF-β1 and
serum significantly augmented collagen gel contraction. TGF-β1 also increased apoptosis assessed
by TUNEL positivity and DNA content analysis. In contrast, serum did not affect apoptosis. TGF-
β1 induction of apoptosis was associated with augmented expression of Bax, a pro-apoptotic
member of the Bax/Bcl-2 family, inhibition of Bcl-2, an anti-apoptotic member of the same family,
and inhibition of both cIAP-1 and XIAP, two inhibitors of the caspase cascade. Serum was
associated with an increase in cIAP-1 and Bcl-2, anti-apoptotic proteins. Interestingly, serum was
also associated with an apparent increase in Bax, a pro-apoptotic protein. Blockade of Smad3 with
either siRNA or by using murine fibroblasts deficient in Smad3 resulted in a lack of TGF-β induction
of augmented contraction and apoptosis. Contraction induced by different factors, therefore, may
be differentially associated with apoptosis, which may be related to the persistence or resolution
of the fibroblasts that accumulate following injury.
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Background
The development of fibrosis is thought to share a number
of important features with normal wound repair. Both
fibrosis and wound repair are characterized by the recruit-
ment and activation of fibroblasts that differentiate to
myofibroblasts [1-3]. These cells accumulate within tis-
sue, produce extracellular matrix and remodel the local
environment. Both fibrotic tissues and normal healing
wounds are also characterized by myofibroblast contrac-
tion of extracellular matrix. Fibrosis, however, differs from
normal wound healing in a number of important respects.
Prominent among these, normal wound healing is charac-
terized by the eventual resorption of much, if not all, of
the excess connective tissue matrix and mesenchymal cells
that characterize the healing phase [4]. In fibrosis, in con-
trast, normal tissue structures are permanently disrupted
by excessive fibrotic material.
The three transforming growth factor-beta (TGF-β) iso-
forms are members of a family of signaling molecules [5].
TGF-β1 is believed to be a key factor in mediating both
mesenchymal cell participation in wound repair and in a
number of pathologic settings in fibrosis [6]. TGF-β is a
potent activator of fibroblasts, inducing their differentia-
tion into myofibroblasts and stimulating their production
of extracellular matrix [7,8]. In in vitro experiments, TGF-
β has been reported to inhibit fibroblast/myofibroblast
apoptosis [9,10]. These in vitro experiments, however,
have evaluated fibroblasts in monolayer culture. Culture
of fibroblasts in three-dimensional collagen gels has been
used as a system that more closely resembles tissues
undergoing repair. These observations, therefore, raise an
interesting and potentially important question: What
would be the effect of TGF-β on the apoptosis of fibrob-
lasts in three-dimensional collagen gel culture? Augmen-
tation of contraction and in addition to apoptosis might
lead to the net accumulation of contracted connective tis-
sue and hence be a mechanism for the development of
fibrosis.
TGF-β1 stimulates fibroblast contraction of extracellular
collagenous matrices [11,12]. Interestingly, fibroblasts in
a contracting matrix have been reported to undergo apop-
tosis [13,14]. The degree of apoptosis, moreover, has been
associated with the degree of contraction in several studies
[13-15]. The current study, therefore, was designed to
determine the effect of TGF-β1 on fibroblast apoptosis in
contracting three-dimensional collagen gels. TGF-β1 was
found to stimulate both contraction of collagen gels and
the apoptosis of fibroblasts in contracting gels. This con-
trasted with a slight inhibition of apoptosis in fibroblasts
in three-dimensional gels that were constrained from con-
tracting. It also contrasted with the effect of serum and
PDGF, which stimulated contraction without stimulating
apoptosis. These results, therefore, suggest that TGF-β1
may stimulate contraction of fibroblasts which, in turn,
may lead to fibroblast apoptosis. Such a coordinated
action may be a key feature of normal tissue repair by pre-
venting the persistent accumulation of fibroblasts within
tissues. These findings suggest that growth factors other
than TGF-β may contribute to the contraction with per-
sistence of fibroblasts that is noted in fibrotic tissues.
Methods
Materials and cell culture
Type I Collagen (rat tail tendon collagen [RTTC]) was
extracted from rat-tail tendons by a previously published
method [16]. Protein concentration was determined by
weighing a lyophilized aliquot from each batch of colla-
gen. The RTTC was stored at 4°C until use. Dulbecco's
modified Eagle's medium (DMEM), fetal calf serum
(FCS), trypsin/EDTA, penicillin G sodium, and strepto-
mycin were purchased from Invitrogen (Life Technolo-
gies, Grand Island, NY). Amphotericin B was purchased
from Pharma-Tek (Elmira, NY). The terminal transferase
dUTP nick end labeling (TUNEL) assay kit was purchased
from Roche Diagnostic Corporation (Indianapolis, IN).
Goat anti-caspase 3 antibody (CRP32), which reacts with
both precursor and active forms of human caspase 3, and
goat anti-PARP, which reacts with both intact and cleaved
forms of human PARP, rabbit anti-cIAP-1 antibody,
mouse anti-XIAP antibody, recombinant human TGF-β1,
PDGF-BB and anti-TGF-β1 antibody were purchased from
R&D Systems (Minneapolis, MN). Mouse anti-Bcl-2 anti-
body and mouse anti-Bax antibody were purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Rabbit
anti-goat and mouse IgG horseradish peroxidase were
purchased from Rockland Immunochemicals (Gilberts-
ville, PA). Propidium iodide, staurosporine and anti-β-
actin antibody were purchased from Sigma (St. Louis,
MO).
Human fetal lung fibroblasts (HFL-1) were obtained from
the American Type Culture Collection (Rockville, MD).
Smad2 knockout and corresponding wildtype, and
Smad3 knockout and corresponding wildtype were kind
gifts from Dr. A. Roberts (NIH). The Smad2 knockout
(S2KO) mouse fibroblasts were established from mouse
embryo-derived fibroblasts harboring the null allele
Smad2∆ex2 in the homozygous state, as described [17,18].
Smad3 knockout (S3KO) mice were generated by targeted
deletion of exon 8 in the Smad3 gene by homologous
recombination, as described [18,19]. The cells were cul-
tured in 100-mm tissue culture dishes (Falcon; Becton-
Dickinson Labware, Lincoln Park, NJ) in Dulbecco's Mod-
ified Eagle's Medium (DMEM), supplemented with 10%
fetal calf serum (FCS), 50 U/ml penicillin G sodium, 50
µg/ml streptomycin sulfate, and 1 µg/ml amphotericin B.
The fibroblasts were refed three times weekly, and cellsRespiratory Research 2005, 6:141 http://respiratory-research.com/content/6/1/141
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between passages 15 to 18 for human and 34 to 45 for
murine were used.
Small interfering RNA (siRNA) for Smad3 was designed to
target the coding sequence of human Smad3 and effec-
tively inhibits Smad protein expression as described previ-
ously [20]. siRNA for Smad2 and non-specific siRNA for
control were purchased from Dharmacon (SMARTpool).
Transfection of siRNA was also performed as described
previously [20]. After 24 hours transfection, HFL-1 cells
were harvested and used for gel contraction assay.
Three-dimensional collagen gel culture
Prior to preparing collagen gels as described below,
fibroblasts were detached by 0.05% trypsin in 0.53 mM
EDTA and suspended in 10 ml serum-free DMEM con-
taining soybean trypsin inhibitor. The cell number was
then counted with Coulter Counter. Collagen gels were
prepared, as previously described [16], by mixing RTTC,
distilled water, 4 × DMEM and cells. The final concentra-
tion was 1 × DMEM, 0.75 mg/ml of collagen, and fibrob-
lasts were present at 3 × 105 cells/ml for human and 4.5 ×
105 cells/ml for murine. Following this, 500 µl of the mix-
ture was cast into each well of a 24-well culture plate (Fal-
con). The solution was then allowed to polymerize at
room temperature, generally completed in 20 min. After
polymerization, the gels were either allowed to remain
attached to the plates in which they were case or, for the
gel contraction assay, the gels were gently released from
the plates in which they were cast and transferred into 60-
mm tissue culture dishes (three gels in each dish), which
contained 5 ml of SF-DMEM with or without FCS, TGF-β1
and PDGF-BB, respectively. The concentrations of TGF-β1
used were based on previous studies [21,22]. The area of
each gel was measured daily with an image analyzer
(Optomax, Burlington, MA). Data are expressed as the
percentage of area compared with the initial gel area. For
attached gels, gels were left attached in the plates and 1 ml
of SF-DMEM with or without FCS or TGF-β1 was added.
The gels were then incubated at 37°C in a 5% CO2 atmos-
phere.
DNA quantification
To estimate cell number in three-dimensional collagen
gels, DNA was assayed fluorometrically with Hoechst dye
no. 33258 (Sigma) by a modification of a previously pub-
lished method [23]. Collagen gels were solubilized by
heating to 60°C for 10 min and cell suspensions were col-
lected by centrifugation at 2,000 × g for 5 min and resus-
pended in 1 ml of distilled water. After sonication, the
suspensions were mixed with 2 ml of TNE buffer (3 M
NaCl, 10 mM Tris, and 1.5 mM EDTA, pH7.4) containing
2 µg/ml of Hoechst dye no. 33258. Fluorescence intensity
was measured with a fluorescence spectrometer (LS-5;
Perkin-Elmer, Boston, MA) with excitation at 356 nm and
emission at 458 nm.
Determination of apoptosis (TUNEL assay)
For determination of apoptosis, TUNEL assay was per-
formed following manufacturer's instructions. Briefly,
collagen gels were transferred from medium or plates
attached to Eppendorf tubes (Fisher, Pittsburgh, PA) and
then solubilized with heating at 60°C for 10 min. This
method effectively solubilized the collagen gels without
resulting in further DNA damage, as assessed by TUNEL
assay (data not shown). Cell suspensions were collected
by centrifugation at 2,000 × g for 5 min and resuspended
in 150 µl of 10% FCS-DMEM. The resuspended cells were
then used to prepare cytospins, 0.5 × 105 cells/spot, 1,000
×  g  for 5 min. Cytospin preparations were fixed with
freshly prepared paraformaldehyde (4% in phosphate-
buffered saline [PBS]; pH 7.4) for 1 h at room tempera-
ture. The cells were permeabilized with 0.1% Triton X-100
(in 0.1% sodium citrate) for 2 min at 4°C and rinsed with
PBS. The TUNEL reaction was then performed using the
manufacturer's instructions (Roche). The number of cells
stained by the TUNEL method was expressed as a percent-
age of the total number of cells stained with the counter-
stain propidium iodide. At least 500 nuclei were counted
on each cytospin sample in 5–10 randomly selected view-
ing fields.
Profile of DNA content by flow cytometry
For three-dimensional collagen gel culture, DNA content
was analysed as described [24]. Briefly, fibroblast-popu-
lated (2 ml of 3 × 105cells/ml) collagen gels were cast into
6-well tissue culture plates (Falcon). After polymerization,
gels were gently released and incubated with 1 % FCS-
DMEM for 24 h, 100 pM TGF-β1 or with 1 µM stau-
rosporine for 6 h (positive control). Gels were then trans-
ferred into 15-ml conical tubes and incubated with 0.05%
Trypsin/0.53 mM EDTA-4Na (Invitrogen) for 10 min
(500 µl/gel) at 37°C in a 5% CO2 atmosphere. Colla-
genase (1 mg/ml in DMEM) was then added (1 ml/gel)
and incubated while shaking at 37°C in a 5% CO2 atmos-
phere for 30 min or until the gels were completely dis-
solved. DMEM containing 10% FCS was then added to
stop the enzymatic reaction, and cells were pelleted by
centrifugation. Cells were then fixed with Telford method
and flow cytometry was performed as described below.
Flow cytometric analysis of DNA content was performed
as previously described [25]. Briefly, cells were fixed with
cold 70% ethanol in PBS for 30 min at 4°C. Cells were
then pelleted by centrifugation and resuspended in the
staining solution (50 µg propidium iodide, 100 µg RNAse
A in 1 ml PBS for 106 cells) at 4°C for 1 h followed by flow
cytometric analysis without washing. Since harvesting
cells from the gels at day 5 results in formation of consid-Respiratory Research 2005, 6:141 http://respiratory-research.com/content/6/1/141
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erable debris which made the DNA profiling assay prob-
lematic, we chose day 1 for DNA profiling.
Western blot analysis
Three-dimensional collagen gel culture was performed as
described above. After collecting cells by centrifugation,
cells were washed with sterile PBS twice, and then put 100
µl cell lysis buffer (35 mM Tris-HCl, pH 7.4, 0.4
mMEGTA, 10 mM MgCl2, 100 µg/ml aprotinin, 1 µM phe-
nylmethylsulfonyl fluoride, 1 µg/ml leupeptin, and 0.1%
Triton X-100). Lysates were briefly sonicated on ice and
centrifuged at 10,000 g for 3 minutes. The protein concen-
tration in the cell lysates was measured using the BIO-
RAD Protein Assay Kit. 10% SDS-polyacrylamide gel elec-
trophoresis was performed under reducing conditions. To
accomplish this, cell lysate proteins were diluted with 2×
concentrated sample buffer (250 mM Tris-HCl, pH 6.9,
4% SDS, 10% glycerol, 0.006% bromphenol blue, 2% β-
mercaptoethanol) and heated at 95°C for 5 minutes
before loading (10 µg/lane). After SDS-PAGE, proteins
were transferred onto PVDF membrane (BIO-RAD). The
membrane was blocked for 1 h at room temperature with
5% skim milk in PBS-Tween and incubated overnight at
4°C with proper each antibody concentrations, respec-
tively. After incubation with HRP-conjugated anti-Rabbit
or mouse-IgG, an ECL Western blot detection system was
used according to the manufacture's instruction (Amer-
sham Biosciences, Piscataway, NJ).
Statistical analysis
Results are presented as mean ± SEM. Statistical compari-
son of paired data was performed using Student's t test,
whereas multigroup data were analyzed by ANOVA fol-
lowed by the Tukey's or Bonferroni's post-test using
Statview software (Abacus Concepts Inc., Cary, NC). P <
0.05 was considered significant.
Results
Effect of FCS and TGF-β1 on fibroblast-mediated collagen 
gel contraction
Both FCS and TGF-β1 increased the contraction of colla-
gen gels in a concentration-dependent manner over the
period of observation. After 5 days, control gels (SF-
DMEM) were 50.0 ± 1.1% of their initial area (Figure 1).
In contrast, gels exposed to FCS (0.1% or 1%) were 21.6 ±
1.0% and 13.1 ± 0.1% of their original size after 5 d,
respectively (Figure 1). Gels exposed to TGF-β1 (10 pM or
100 pM) were 32.8 ± 0.5% and 28.8 ± 1.5% of their orig-
inal size after 5 d, respectively (Figure 1). The effect of FCS
and TGF-β1 were both concentration- and time-depend-
ent. Addition of anti-TGF-β antibodies did not alter the
effect of serum but did completely block the effect of TGF-
β (data not shown).
Effect of FCS and TGF-β1 on apoptosis
To determine the effect of FCS and TGF-β1 on fibroblast
apoptosis, two methods were used. First, cells in three-
dimensional collagen gels were cultured in SF-DMEM,
0.1% or 1%FCS-DMEM, 10 pM or 100 pM TGF-β1, and as
an additional comparator 100 pM PDGF-BB for 5 days,
and then TUNEL staining which measures DNA strand
breaks, a feature of apoptosis cells, was performed (Figure
2). After 5 days, 11.6 ± 0.3% of control cells were TUNEL
positive (Figure 3). TGF-β treated cells had increased
TUNEL positivity while FCS treated cells had decreased
TUNEL positivity. To quantify this, 500 cells from each
condition were counted. In the presence of 0.1% FCS or
1% FCS, 10.3 ±0.5% and 7.1 ± 0.9% of the cells were
TUNEL positive, respectively (Figure 3). PDGF-BB (100
pM) stimulated gel contraction similarly to TGF-β1 (data
not shown) but did not result in increased apoptosis
above control, 10.8 ± 0.4% of the PDGF-BB treated cells
were TUNEL positive. In contrast, in the presence of 10
pM or 100 pM TGF-β1, TUNEL positive cell numbers were
significantly increased to 22.3 ± 0.4% and 31.4 ± 1.4%,
respectively (Figure 3) (p < 0.05, compared with control).
To confirm the presence of apoptosis, profiling of DNA
content was performed by flow cytometry. As a positive
control, a group of gels were treated with staurosporin.
After 24-hours, 1% FCS had tendency to decrease the
Effect of TGF-β1 and FCS on collagen gel contraction medi- ated by HFL-1 cells Figure 1
Effect of TGF-β1 and FCS on collagen gel contraction 
mediated by HFL-1 cells. Fibroblast-populated collagen 
gels were released into 60 mm tissue culture dishes with or 
without FCS or TGF-β1. Gel size was measured daily with an 
image analyzer. Vertical axis: gel size expressed as % of initial 
size. Horizontal axis: Time (days of culture). Both serum and 
TGF-β1 significantly augmented collagen gel contraction in a 
concentration-dependent manner. *p < 0.05 as compared 
with control. Data are shown as means ± SEM. Data pre-
sented are from one representative experiment of three 
experiments performed on separate occasions.
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amount of hypodiploid DNA compared to control cul-
tures. In contrast, the TGF-β1 group increased the amount
of hypodiploid DNA compared to control, indicating
TGF-β1 increased apoptosis while FCS did not (Figure 4).
Time course of cell numbers in three-dimensional collagen 
gel
To further confirm that apoptosis was occurring, the DNA
amount, which can be used as a surrogate for cell number,
was assessed in floating collagen gels. After casting gels in
the presence of either serum-free DMEM, 1% fetal calf
serum or 100 pM TGF-β1, DNA amount was assessed after
5 and after 10 days without further refeeding. As expected,
DNA content decreased over time in control cultures incu-
bated in DMEM alone. In the presence of 1% FCS, DNA
amount decreased, but the decrease was statistically signif-
icantly less than that which occurred under control condi-
tions (p < 0.05). In contrast, in the presence of TGF-β1,
the decrease in DNA amount was larger than that which
occurred in control (p < 0.05).
Effect of FCS and TGF-β1 on apoptosis related protein 
expression
A large number of proteins can serve as positive or nega-
tive regulators of the apoptosis process. To further con-
firm the differential effect of fetal calf serum and TGF-β1
on apoptosis, several apoptosis-related proteins were eval-
uated by Western blot (Figure 6). Staurosporin, which is
an active control and induced apoptosis, increased the
expression of Bax and induced the cleavage of both PARP
TUNEL staining in HFL-1 cells Figure 2
TUNEL staining in HFL-1 cells. Fibroblast-populated collagen gels were released into 60 mm tissue culture dishes with or 
without FCS or TGF-β1. On day 5, collagen gels were digested, cells isolated, cytocentrifuge preparation made, and stained by 
TUNEL. A: positive control (DNAse-1 treated), B: negative control (without terminal transferase), C: FCS free, D: FCS 1%, E: 
TGF-β1(100 pM). Red: PI stained normal cells. Green: TUNEL positive cells. Data presented are from one representative 
experiment. Similar results were obtained in three experiments performed on separate occasions.Respiratory Research 2005, 6:141 http://respiratory-research.com/content/6/1/141
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and caspase 3, three markers of active apoptosis while it
simultaneously inhibited the expression of Bcl-2, cIAP-1
and XIAP, three inhibitors of apoptosis. In contrast to the
effects of staurosporin, 1% FCS stimulated the expression
of Bcl-2, cIAP-1 and XIAP, the inhibitors of apoptosis,
while it resulted in no cleavage of PARP or caspase 3. TGF-
β1, in contrast, resembled staurosporin by increasing the
expression of Bax and initiating the cleavage of PARP and
caspase 3, all markers of active apoptosis, while it simul-
taneously inhibited the expression of Bcl-2 and XIAP.
Effect of FCS and TGF-β1 on apoptosis in the attached gels
To determine if the effect of FCS and TGF-β1 on fibroblast
apoptosis in collagen gels was related to contraction, cells
in three-dimensional collagen gels were cultured in SF-
DMEM, 1% FCS-DMEM or 100 pM TGF-β1 for 5 days and
the gels were left attached to the plates, which prevents
contraction. After this, the cultures were harvested and
TUNEL staining was performed (Figure 7A). In contrast to
contracting gels, 100 pM TGF-β1 did not significantly
increase the percentage of TUNEL positive cells in
attached gels. Similarly, in contrast to the effect on float-
ing gels, TGF-β exposure had no effect in activating cas-
pase 3 in gels that were constrained from contracting
(Figure 7B).
Role of Smad2 and Smad3 in TGF-β induced apoptosis of 
fibroblasts in floating collagen gels
To determine the role of Smad2 and Smad3 on fibroblasts
apoptosis, two methods were used. Murine lung fibrob-
lasts from S2KO and S3KO and the corresponding
wildtype (S2WT and S3WT) and HFL-1 cells incubated
with siRNA targeting Smad2 and Smad3 were cultured in
3-D collagen gels with or without TGF-β1. As expected,
TGF-β1 did not induced augmented contraction in Smad3
KO cells as previously described [11] or in Smad3 siRNA
treated HFL-1 cells (data not shown). In contrast, TGF-β1
significantly augmented contraction in Smad2 KO cells in
both wildtype controls [11] and in Smad2 siRNA treated
and control HFL-1 cells (data not shown). After 5 days,
TUNEL staining was performed. S2KO cells and both
types of wildtype control cells as well as Smad2 siRNA
treated and control HFL-1 cells had increased TUNEL pos-
itivity after TGF-β1 treatment (Figure 8). In contrast, TGF-
β1 had no effect on TUNEL positivity in either Smad3
knockout mouse or Smad3 siRNA treated HFL-1 cells.
Similarly, TGF-β did not result in the activation of caspase
3 in Smad3 siRNA treated HFL-1 cells (Figure 9).
Discussion
The current study evaluated the survival of fibroblasts in
contracting three-dimensional collagen gels. As expected,
TGF-β1, PDGF-BB and serum all stimulated fibroblast-
mediated contraction of three-dimensional collagen gels.
TGF-β1 also stimulated apoptosis in the fibroblasts as
assessed by both TUNEL assay and confirmed by DNA
profiling to quantify cells with hypodiploid DNA content.
In contrast, neither fetal calf serum nor PDGF-BB altered
fibroblast apoptosis in contracting collagen gels. The stim-
ulatory effect of TGF-β1 on apoptosis was associated with
an increase in pro-apoptotic markers, including cleaved
caspase 3, Bax and cleaved PARP, as well as inhibition of
anti-apoptotic factors, including Bcl-2, cIAP-1 and XIAP.
The ability of TGF-β1 to stimulate apoptosis required con-
traction of the three-dimensional collagen gels as no
induction of apoptosis was noted in gels that were con-
strained from contraction.
TGF-β1 is one of three TGF-β isoforms that are members
of a family of signaling molecules [5] TGF-β1 is believed
to be a key factor in a variety of physiological and disease
processes mediating a diverse range of cellular responses,
including down regulation of inflammation, stimulation
or inhibition of various cells types and regulation of dif-
ferentiation of many target cells. TGF-β1 is believed to
play a particularly important role as a mediator of wound
healing [6]. TGF-β1 is a potent activator of fibroblasts
stimulating fibroblast proliferation, production of extra-
cellular matrix and differentiation into myofibroblasts.
Because of these actions, TGF-β1 driven fibroblast activa-
TUNEL positivity in HFL-1 with FCS, TGF-β1 and PDGF-BB Figure 3
TUNEL positivity in HFL-1 with FCS, TGF-β1 and 
PDGF-BB. After staining, TUNEL positive cells as a % of 
total cells were counted under the microscope in 5 high-
power fields. Vertical axis: TUNEL positivity expressed as % 
of positive control (DNAse treated). Horizontal axis: condi-
tion. TGF-β1 increased TUNEL positivity. In contrast, FCS or 
PDGF-BB did not affect TUNEL positivity. *p < 0.05, as com-
pared with control. Data are shown as means ± SEM. Data 
presented are from one representative experiment of three 
experiments performed on separate occasions.
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tion is believed to play a major role in wound repair, scar
formation and tissue fibrosis [26,27].
Tissue fibrosis differs from normal wound repair in sev-
eral important features. While both are characterized by
proliferation and accumulation of fibroblasts together
with the extracellular matrix produced by these cells, nor-
mal granulation tissue is characterized by a resolution
phase [28]. Specifically, as granulation tissue contracts,
fibroblast apoptosis together with resorption of some of
the collagenous extracellular matrix characteristically
takes place. In fibrotic tissues, the severity of scarring and
fibrosis, therefore, is dependent not only on the degree of
fibroblast activation, but also on the relative lack of reso-
lution. While the mechanisms that regulate resolution are
incompletely understood, the current study supports the
concept that TGF-β1 can drive fibroblast apoptosis con-
current with tissue contraction and that TGF-β1 differs
from other growth factors in this regard. These results,
which were obtained with fibroblasts cultured in three-
dimensional collagen gels, contrast markedly with previ-
ous studies that evaluated fibroblasts cultured in monol-
ayer culture where TGF-β inhibits apoptosis.
The members of the TGF-β family signal through a family
of receptors, the activin receptors, which in turn signal
Representative profile of DNA content in fibroblasts Figure 4
Representative profile of DNA content in fibroblasts. Collagen gels with fibroblasts were floated in (A) Staurosporine 1 
µM for 6 hours, (B) SF-DMEM, (C) 1% FCS-DMEM and (D) TGF-β1 100 pM for 24 hours. Cells were then isolated and ana-
lyzed by flow cytometry. Vertical axis: cell number; horizontal axis: DNA content. The percentage of cells with hypodiploid DNA 
taken as an index of apoptosis is shown in each panel. Figure presented is from one representative experiment of three exper-
iments performed on separate occasions. *p < 0.01. Data are shown as means ± SEM. Comparison of the means were done by 
one-way ANOVA.
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through a family of signal transduction molecules, the
Smads [29]. TGF-β signals primarily through the TGF-β
RII (activin IIB) which phosphorylates the TGF-β RI
(activin I). The activin I receptor, in turn, phosphorylates
two Smad proteins, Smad 2 and Smad 3, which subse-
quently bind Smad 4 and mediate TGF-β signaling. While
these represent the best characterized mechanisms for
TGF-β signaling, other signaling pathways independent of
Smad 2 and 3 have been reported [30]. The concentra-
tions of TGF-β used in the current study were based on
previous in vitro studies and are in the range expected for
TGF-β to be active on its receptor. In vivo concentrations
of TGF-β have been measured and are generally many-fold
greater than those used. In vitro measurements, however,
have generally assessed total TGF-β rather than the active
form. Thus, while measures of in vivo active TGF-β con-
centrations are unavailable, the concentrations used in the
current study are likely to be biologically relevant.
The culture of fibroblasts in three-dimensional collagen
gels has been used for several decades as a model of tissue
contraction that characterizes wound healing [1]. When
cultured in floating collagen gels, fibroblasts attach to the
collagenous matrix through integrin-dependent mecha-
nisms and exert mechanical tension, which can cause
floating gels to contract. In addition, concurrent with con-
traction, fibroblasts undergo apoptosis [13-15]. Interest-
ingly, the amount of apoptosis is related to the amount of
contraction [13,14]. Gels prepared with smaller concen-
trations of collagen, for example, undergo greater degrees
of contraction, and a higher percentage of fibroblasts
undergo apoptosis [14]. While the mechanisms that regu-
late apoptosis under these conditions are not fully estab-
lished, cell spreading may play a role [31]. Specifically,
cells that are not effectively spread are susceptible to apop-
tosis. Contraction, therefore, may be related to apoptosis
induction. An effect of mechanical tension may also play
a role. Finally, although our results suggest that contrac-
tion, per se, is related to induction of apoptosis, it is pos-
sible that other effects of TGF-β that also depend on
Smad3 signaling mediate this effect.
Fibroblasts cultured in collagen gels can also proliferate.
However, their response to growth factors in gel culture
can be attenuated. Under the conditions used in the cur-
rent assay, we have previously shown that there is mini-
mal stimulation of proliferation with serum
concentration 1% or less [16]. Serum contains many fac-
tors that can inhibit apoptosis [32], although the factors
involved remained to be defined. Whether serum stimula-
tion of contraction results from the same factor(s) that
block apoptosis remain to be determined, although PDGF
can do both. The overall effect of serum, however, con-
trasts with that of TGF-β. The link between TGF-β induced
contraction and apoptosis may be a mechanism to pre-
vent the accumulation of fibroblasts in resolving wounds.
In contrast, the persistence of fibroblasts induced by other
factor(s) present in serum may be a mechanism that con-
tributes to scar formation or fibrosis.
The key finding of the current study is that augmented
contraction induced by TGF-β is associated with apopto-
sis. This contrasts with augmented contraction induced by
either PDGF or serum that is not associated with aug-
mented apoptosis. These results suggest that contraction
that takes place in the presence of TGF-β can be associated
with apoptosis of fibroblasts. While TGF-β has been sug-
gested to be a ''pro-fibrotic'' mediator because of its fre-
quent association with both tissue injury and repair and
with fibrotic processes and with its ability to activate
fibroblasts, the present study suggests that TGF-β may
stimulate fibroblasts in such a way that ''resolution'' is
possible. The failure of apoptosis to occur in the presence
of augmented contraction induced by PDGF and serum,
however, suggests that other growth factors, that could
function in collaboration with TGF-β, may be responsible
for the persistence of fibroblasts and, hence, the develop-
ment of fibrosis.
In order to determine the mechanisms by which TGF-β
signaling leads to apoptosis, two approaches were used.
TGF-β signaling was suppressed using siRNAs for either
Smad 2 or Smad 3 and fibroblasts cultured from Smad 2
or Smad 3 deficient mice were compared with appropriate
DNA amount in contracting collagen gels Figure 5
DNA amount in contracting collagen gels. Fibroblasts 
were embedded in collagen gels and cultured in floating 
media containing 1% FCS or 100 pM TGF-β1 or control. 
DNA content, as a surrogate for cell number, was deter-
mined at the time of plating and after 5 and 10 days. *P < 
0.05, as compared with SF-DMEM. Data are shown as means 
± SEM.
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controls. As previously described [11], the absence of
Smad 2 signaling had no effect on TGF-β1 or PDGF-BB
stimulation of collagen gel contraction, while the absence
of Smad 3 signaling blocked the ability of TGF-β1 to aug-
ment contraction, but not the ability of PDGF-BB to aug-
ment contraction. Using both siRNA and genetically
deficient mice, loss of Smad 2 signaling had no effect on
TGF-β1 augmentation of apoptosis, while loss of Smad 3
signaling blocked the ability of TGF-β1 to augment apop-
tosis. Thus, inhibition of apoptosis was always associated
with inhibition of contraction.
The effect of TGF-β contrasted with the effect of serum
which augmented contraction but did not stimulate apop-
tosis. These differing effects on apoptosis were paralleled
by effects on apoptosis-related proteins. The mechanisms
that prevent apoptosis in the presence of serum (or PDGF-
BB) are unclear. In the present study, neither PDGF-BB
nor serum affected apoptosis in a statistically significant
manner. However, a small inhibition of apoptosis that
did not achieve statistical significance was observed. Thus,
it is possible that PDGF-BB or other growth factors could
actively suppress apoptosis. In this context, the presence
of serum was associated with an increase in cIAP-1 and
Bcl-2, anti-apoptotic proteins. Interestingly, serum was
Western blots of selected pro-apoptotic and anti-apoptotic factors Figure 6
Western blots of selected pro-apoptotic and anti-apoptotic factors. Fibroblasts were embedded in collagen gel and 
cultured in floating media with 1% FCS, 100 pM TGF-β1, staurosporine or control. After a day, collagen gels were digested, 
cells were collected, lysed and the cell lysate evaluated by Western blot. Data presented are from one representative experi-
ment. Similar results were obtained in three experiments performed on separate occasions.
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also associated with an apparent increase in Bax, a pro-
apoptotic protein. It seems likely, therefore, that factors
present in serum may be able to affect the balance
between pro- and anti-apoptotic factors and through such
mechanisms could stimulate contraction while inhibiting
apoptosis.
Apoptosis, or programmed cell death, is a highly regu-
lated intracellular process. It can be initiated through sev-
eral signaling mechanisms, including both activation of
specific receptors as well as through non-specific effects
such as DNA damage [33-35]. Apoptosis is regulated at
several levels. Important among these is the proteolytic
caspase cascade [36]. The caspases form a series of enzy-
matic reactions that, through successive cleavage events,
can lead to the activation of caspase 3 which functions as
a "cellular executioner." Concurrently, proteolytic cleav-
age can degrade the enzyme PARP which serves to main-
tain DNA integrity. The cleavage of PARP, an enzyme that
mediates DNA repair, is believed to be an early step that
commits a cell to death rather than DNA repair [37,38].
Similarly, cleavage of caspase 3 to its active form is
believed to be a step that commits a cell to apoptosis as
caspase 3 subsequently degrades many key cellular pro-
teins. The commitment of a cell to apoptosis, therefore,
can be regulated by controlling the activity of caspases.
Several mechanisms exist by which this can be accom-
plished, including the release of the co-factor cytochrome
C from mitochondria [39], which is both positively and
TUNEL positivity and Western blot of selected pro-apop- totic and anti-apoptotic factors in murine fibroblasts and  HFL-1 cells with or without TGF-β1 Figure 8
TUNEL positivity and Western blot of selected pro-
apoptotic and anti-apoptotic factors in murine 
fibroblasts and HFL-1 cells with or without TGF-β1. 
After staining, TUNEL positive cells as a % of total cells were 
counted under the microscope in 5 high-power fields. Panel 
A: Murine Smad3 KO and control cells; Panel B: HFL-1 cells 
± siRNAs. Vertical axis: TUNEL positivity expressed as % of 
positive control (DNAse treated). Horizontal axis: condition. 
TGF-β1 increased TUNEL positivity in all cell types except in 
S3KO cells (Panel A) and Smad3 siRNA cells (Panel B). *p < 
0.05, as compared with control. Data are shown as means ± 
SEM. Data presented are from one representative experi-
ment of three experiments performed on separate occa-
sions.
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TUNEL positivity in HFL-1 cells cultured in attached 
gels and Western blots for selected pro-apoptotic 
and anti-apoptotic factors. TUNEL Positivity. (A) Fibrob-
lasts embedded in collagen gels which were left attached to 
the plates preventing contraction. After 5 days, gels were 
digested and stained for TUNEL. TUNEL positive cells were 
counted in 5 high-power fields and expressed as % of total 
cells. Data are presented as % of positive control (DNAse 
treated). Data are shown as means ± SEM. Western blot for 
selected pro-apoptotic and anti-apoptotic factors. (B) Colla-
gen gels were digested, cells were collected, lysed and the 
cell lysate were evaluated by Western blot. Data presented 
are from one representative experiment.
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negatively regulated by members of the Bax/Bcl family
and by regulation through a family of inhibitors of cas-
pases [40]. In this context, TGF-β1 induction of apoptosis
in contracting three-dimensional collagen gels was associ-
ated with augmented expression of Bax, a pro-apoptotic
member of the Bax/Bcl-2 family together with inhibition
of Bcl-2, an anti-apoptotic member of the same family.
Similarly, TGF-β1 was associated with inhibition of both
cIAP-1 and XIAP, two inhibitors of the caspase cascade.
The mechanisms by which TGF-β induces these effects are
beyond the scope of the current proposal, but appears to
require contraction of the three-dimensional collagen
gels. This raises the possibility that the effect of TGF-β is
indirect and may be related to cell spreading, for example.
In conclusion, the current study demonstrates that TGF-
β1 induction of three-dimensional collagen gel contrac-
tion is associated with apoptosis. This induction of apop-
tosis requires contraction of the three-dimensional
collagen gels and differs from other factors, including
serum and PDGF-BB that induce contraction but not
apoptosis. The ability of TGF-β to induce apoptosis may
play a key role during wound repair. Abnormal regulation
of apoptosis during the resolution phase following tissue
repair could contribute importantly to both hypertrophic
scar formation as well as to tissue fibrosis. The ability of
tissues to contract normally may be important in this
regard, and processes that increase mechanical tension in
tissues or constrain contraction by other mechanisms may
contribute to fibrosis and tissue remodeling. This study,
therefore, supports the concept that TGF-β induction of
fibroblast apoptosis is one of its many functions related to
tissue repair and remodeling. Alterations in this function
could contribute to the formation of hypertrophic scar or
tissue fibrosis.
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